Daniel R. Marshak, PerkinElmer
Daniel R. Marshak, Ph.D., serves as senior vice president & chief scientific officer for PerkinElmer since joining the Company in 2006. Dr. Marshak leads PerkinElmer’s research and development functions, while helping to drive growth strategies across the organization.
From 2008 to 2010, Dr. Marshak was based in Shanghai where he also led PerkinElmer in Greater China and was responsible for expanding its commercial operations and resources in the region to drive significant revenue growth. This included innovation and new product development as well as a move into clinical diagnostics in the areas of infectious disease and oncology. He subsequently led the Company's diagnostics business in emerging markets, expanding efforts in cutting-edge scientific areas such as mass spectrometry and nucleic acid testing.
Prior to joining PerkinElmer, Dr. Marshak was vice president and chief technology officer, Biotechnology, for Cambrex Corporation. He previously served as senior vice president and chief scientific officer for Osiris Therapeutics, Inc., where he led stem cell research and development from inception to late-stage clinical trials. He was previously a senior staff investigator at Cold Spring Harbor Laboratory in New York.
Dr. Marshak has received numerous awards for scientific and academic achievements, and is named on six issued U.S. patents. He also serves on the Board of Directors for the International Society for Stem Cell Research.
Dr. Marshak is the author of more than 100 scientific publications, including one textbook, and has been editor of five monographs. He recently held an appointment as adjunct associate professor at the Johns Hopkins University School of Medicine, and previously taught graduate biochemistry as assistant professor at the State University of New York.
Dr. Marshak received his Bachelor of Arts degree in biochemistry and molecular biology from Harvard University, and holds a doctorate in biochemistry and cell biology from The Rockefeller University. , and holds a doctorate in biochemistry and cell biology from The Rockefeller University.
« Go back